![]() |
Market Research Report
Product code
1044766
Single-use Bioreactors Market Size, Share & Trends Analysis Report By Product, By Type, By Type of Cell, By Molecule Type, By Application, By End Use, By Usage Type, By Region, And Segment Forecasts, 2021 - 2028 |
Single-use Bioreactors Market Size, Share & Trends Analysis Report By Product, By Type, By Type of Cell, By Molecule Type, By Application, By End Use, By Usage Type, By Region, And Segment Forecasts, 2021 - 2028 |
Published: December 28, 2021
Grand View Research, Inc.
Content info: 160 Pages
Delivery time: 2-10 business days
|
The global single-use bioreactors market size is expected to reach USD 7.76 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 17.0% from 2021 to 2028. An increase in the demand for disposable bioreactors, coupled with the rapidly growing biopharmaceutical product demand, is leading to significant investments in this space. The outbreak of COVID-19 has created significant demand for single-use bioreactors as there is high demand for large-scale vaccine production across the globe.
Continuous strategic initiatives undertaken by emerging as well as established market entities for the expansion of capabilities are expected to positively impact the market growth. For instance, in July 2021, Cytiva and Pall Corporation announced plans to expand their manufacturing capacity and services globally as they will invest over USD 300 million in single-use technologies as well as bioreactor bags for growing cells that are used to make syringe filters and customized medicines for research.
A rise in biopharmaceutical research & development also has a significant influence on the market growth. Applications of disposable bioreactors in COVID-19 vaccine manufacturing are fueling industrial growth. As the vaccine development process is complex, key companies are collaborating with research institutes on various fronts such as process development approaches, in turn, increasing the adoption of SUBs for R&D.
North America dominated the market in 2020 owing to the increasing adoption of SUBs, coupled with the presence of major biopharmaceutical and biotechnology industries. Asia Pacific is projected to expand at the fastest CAGR over the forecast period, with China being the largest country contributing to the market growth.